GBCDRlnc1 interacts with PGK1 protein, inhibits its ubiquitination and degradation, increases the expression of ATG5‐ATG12 conjugate as a downstream target, promotes tumour cell autophagy and induces DOX resistance.37, 38. Here, ATG5 is linked to neoplasm.